<SEC-DOCUMENT>0001104659-11-028405.txt : 20110512
<SEC-HEADER>0001104659-11-028405.hdr.sgml : 20110512
<ACCEPTANCE-DATETIME>20110512083441
ACCESSION NUMBER:		0001104659-11-028405
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20110512
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20110512
DATE AS OF CHANGE:		20110512

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIO KEY INTERNATIONAL INC
		CENTRAL INDEX KEY:			0001019034
		STANDARD INDUSTRIAL CLASSIFICATION:	COMPUTER COMMUNICATIONS EQUIPMENT [3576]
		IRS NUMBER:				411761861
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13463
		FILM NUMBER:		11833871

	BUSINESS ADDRESS:	
		STREET 1:		3349 HIGHWAY 138
		STREET 2:		BUIDING D, SUITE B
		CITY:			WALL
		STATE:			NJ
		ZIP:			07719
		BUSINESS PHONE:		6516870414

	MAIL ADDRESS:	
		STREET 1:		3349 HIGHWAY 138
		STREET 2:		BUIDING D, SUITE B
		CITY:			WALL
		STATE:			NJ
		ZIP:			07719

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SAC TECHNOLOGIES INC
		DATE OF NAME CHANGE:	19961115
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a11-12050_18k.htm
<DESCRIPTION>8-K
<TEXT>


<html>
<head>

  </head>
<body lang="EN-US">
<div style="font-family:Times New Roman;">
<div style="border-bottom:solid windowtext 1.0pt;border-left:none;border-right:none;border-top:solid windowtext 3.0pt;padding:1.0pt 0in 1.0pt 0in;">
<p style="border:none;margin:0in 0in .0001pt;padding:0in;"><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
</div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">UNITED STATES</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Washington, D.C. 20549</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">FORM&nbsp;8-K</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">CURRENT REPORT</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">Pursuant to Section&nbsp;13 or 15(d)&nbsp;of the Securities Exchange Act of 1934</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date of Report (Date of earliest event reported): <b>May&nbsp;12, 2011</b></font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">BIO-key International,&nbsp;Inc.</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Exact name of registrant as specified in its charter)</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div align="center">
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="34%" valign="top" style="padding:0in 0in 0in 0in;width:34.42%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Delaware</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.26%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="26%" valign="top" style="padding:0in 0in 0in 0in;width:26.66%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">1-13463</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.08%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="34%" valign="top" style="padding:0in 0in 0in 0in;width:34.58%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">41-1741861</font></b></p>    </td>   </tr>
<tr>
<td width="34%" valign="top" style="padding:0in 0in 0in 0in;width:34.42%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(State or other jurisdiction of <br>   incorporation)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="26%" valign="top" style="padding:0in 0in 0in 0in;width:26.66%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Commission File Number)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.08%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="34%" valign="top" style="padding:0in 0in 0in 0in;width:34.58%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(I.R.S. Employer Identification No.)</font></p>    </td>   </tr>  </table>
</div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">3349 Highway 138, Building D, Suite&nbsp;B</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Wall, NJ 07719</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Address of principal executive offices)</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(732)&nbsp;359-1100</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Registrant&#146;s telephone number, including area code)</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Check the appropriate box below if the Form&nbsp;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<i>see</i> General Instruction A.2 below):</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Written communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425)</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Soliciting material pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Pre-commencement communications pursuant to Rule&nbsp;14d-2(b)&nbsp;under the Exchange Act (17 CFR 240.14d-2(b))</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Pre-commencement communications pursuant to Rule&nbsp;13e-4(c)&nbsp;under Exchange Act (17 CFR 240.13e-4(c))</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="border-bottom:solid windowtext 3.0pt;border-left:none;border-right:none;border-top:solid windowtext 1.0pt;padding:1.0pt 0in 1.0pt 0in;">
<p style="border:none;margin:0in 0in .0001pt;padding:0in;"><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
</div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\106459\11-12050-1\task4678873\12050-1-ba.htm',USER='106459',CD='May 11 12:59 2011' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="8%" valign="top" style="padding:0in 0in 0in 0in;width:8.92%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item   2.02.</font></b></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.16%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="87%" valign="top" style="padding:0in 0in 0in 0in;width:87.92%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Results   of Operations and Financial Condition.</font></b></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On May&nbsp;12, 2011, BIO-key International,&nbsp;Inc. (the &#147;Company&#148;) issued a press release announcing its financial results for its first quarter ended March&nbsp;31, 2011 which is included as an exhibit to a Current Report on Form&nbsp;8-K.&nbsp;A copy of the press release issued by the Company on May&nbsp;12, 2011 is attached as Exhibit&nbsp;99.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:49.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The information, including the exhibit attached hereto, in this Current Report on Form&nbsp;8-K shall not be deemed &#147;filed&#148; for purposes of Section&nbsp;18 of the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as otherwise expressly stated in such filing.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="8%" valign="top" style="padding:0in 0in 0in 0in;width:8.92%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item   9.01.</font></b></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.16%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="87%" valign="top" style="padding:0in 0in 0in 0in;width:87.92%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Financial   Statements, Pro Forma Financial Information and Exhibit.</font></b></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="92%" valign="top" style="padding:0in 0in 0in 0in;width:92.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibits</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="92%" valign="top" style="padding:0in 0in 0in 0in;width:92.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">99.1</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="92%" valign="top" style="padding:0in 0in 0in 0in;width:92.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Press Release, dated May&nbsp;12, 2011, issued by </font><font size="2" style="font-size:10.0pt;">the Company.</font></p>    </td>   </tr>  </table>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2<a name="PB_2_124132_5335"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='2',FILE='C:\JMS\106459\11-12050-1\task4678873\12050-1-ba.htm',USER='106459',CD='May 11 12:59 2011' -->

<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">SIGNATURES</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="49%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:49.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">BIO-KEY INTERNATIONAL,&nbsp;INC.</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date: May&nbsp;12, 2011</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="45%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:45.58%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ Cecilia C. Welch</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:45.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Cecilia   C. Welch</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Chief   Financial Officer</font></p>    </td>   </tr>  </table>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3<a name="PB_3_124238_5796"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='3',FILE='C:\JMS\106459\11-12050-1\task4678873\12050-1-ba.htm',USER='106459',CD='May 11 12:59 2011' -->

<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">EXHIBIT&nbsp;INDEX</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="8%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:8.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Exhibit&nbsp;No.</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.76%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="88%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:88.76%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Description</font></b></p>    </td>   </tr>
<tr>
<td width="8%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:8.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.76%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="88%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:88.76%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="8%" valign="top" style="padding:0in 0in 0in 0in;width:8.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">99.1</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.76%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="88%" valign="top" style="padding:0in 0in 0in 0in;width:88.76%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Press   Release, dated May&nbsp;12, 2011,   issued by the Company.</font></p>    </td>   </tr>  </table>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4<a name="PB_4_124332_2897"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='4',FILE='C:\JMS\106459\11-12050-1\task4678873\12050-1-ba.htm',USER='106459',CD='May 11 12:59 2011' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a11-12050_1ex99d1.htm
<DESCRIPTION>EX-99.1
<TEXT>


<html>
<head>

  </head>
<body lang="EN-US">
<div style="font-family:Times New Roman;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit 99.1</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="64%" rowspan="9" valign="top" style="padding:0in 0in 0in 0in;width:64.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman"><img width="192" height="140" src="g120501mmi001.jpg"></font></p>    </td>
<td width="35%" colspan="2" style="padding:0in 0in 0in 0in;width:35.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="35%" colspan="2" style="padding:0in 0in 0in 0in;width:35.84%;">
<p style="margin:0in 0in .0001pt;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">&nbsp;</font></i></b></p>    </td>   </tr>
<tr>
<td width="35%" colspan="2" style="padding:0in 0in 0in 0in;width:35.84%;">
<p style="margin:0in 0in .0001pt;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">&nbsp;</font></i></b></p>    </td>   </tr>
<tr>
<td width="35%" colspan="2" style="padding:0in 0in 0in 0in;width:35.84%;">
<p style="margin:0in 0in .0001pt;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">&nbsp;</font></i></b></p>    </td>   </tr>
<tr>
<td width="35%" colspan="2" style="padding:0in 0in 0in 0in;width:35.84%;">
<p align="center" style="margin:0in 0in .0001pt 10.0pt;text-align:center;text-indent:-10.0pt;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">NEWS   RELEASE</font></i></b></p>    </td>   </tr>
<tr>
<td width="35%" colspan="2" style="padding:0in 0in 0in 0in;width:35.84%;">
<p style="margin:0in 0in .0001pt;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">&nbsp;</font></i></b></p>    </td>   </tr>
<tr>
<td width="8%" valign="top" style="padding:0in 0in 0in 0in;width:8.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Contacts:</font></p>    </td>
<td width="27%" valign="top" style="padding:0in 0in 0in 0in;width:27.26%;">
<p style="margin:0in 0in .0001pt;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">BIO-key   International,&nbsp;Inc.</font></u></p>    </td>   </tr>
<tr>
<td width="8%" valign="top" style="padding:0in 0in 0in 0in;width:8.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="27%" valign="top" style="padding:0in 0in 0in 0in;width:27.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Scott   Mahnken</font></p>    </td>   </tr>
<tr>
<td width="8%" valign="top" style="padding:0in 0in 0in 0in;width:8.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="27%" valign="top" style="padding:0in 0in 0in 0in;width:27.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">732-359-1113</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">BIO-key&#174; Reports 2011 First Quarter Financial Results</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Sales increase 44%, and operating income increases $403,000</font></i></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Wall, NJ, May&nbsp;12, 2011</font></b><font size="2" style="font-size:10.0pt;"> &#151; BIO-key International,&nbsp;Inc. (OTC Bulletin Board: BKYI), a leader in finger-based biometric identification solutions, today reported financial results for the first quarter ended March&nbsp;31, 2011.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Total revenue for the three months ended March&nbsp;31, 2011 was approximately $1.4 million, representing an increase of 44% from the $976,175 reported for the quarter ended March&nbsp;31, 2010.&nbsp; The increase in net sales is primarily attributed to a large international contract the Company received in late 2010 and partially delivered in the first quarter, as well as new license fees related to the ongoing service of several healthcare and government related accounts.&#160; Additionally, the Company reported an increase in service revenues of approximately 72%, which was driven by a mix of both new accounts and renewed maintenance agreements from legacy customers.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">BIO-key&#146;s gross margin for the first quarter of 2011 was 92% compared to 89% for the same period in 2010.&nbsp; Operating expenses for the first quarter of 2011 increased 2.2% to approximately $1.0 million compared to $984,809 in the comparable quarter ended March&nbsp;31, 2010.&nbsp;Operating income for the first quarter of 2011 was $283,988, a $403,000 improvement over the operating loss of ($118,734) reported in the quarter ended March&nbsp;31, 2010.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Net income for the first quarter of 2011 was $240,071 compared to net income of approximately $1.0 million for the comparable quarter in 2010.&#160; Net income for the 2010 period included approximately $787,000 in income related to derivative and fair value adjustments and $435,318 in income from discontinued operations.&#160; Excluding the impact of these events, net income would have increased by approximately $462,000.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;We are pleased with our performance in the first quarter and believe the upcoming periods will show sequential improvements to both our top and bottom-line given the backlog in place at the end of the quarter, as well as several projects that remain in our pipeline,&#148; said Michael DePasquale, BIO-key&#146;s Chief Executive Officer.&#160; &#147;Additionally, we continue to see increased demand for fingerprint biometrics from both our domestic and international customers and channel partners, though the sales cycle at times, has taken longer than</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\106459\11-12050-1\task4678873\12050-1-mm.htm',USER='106459',CD='May 11 13:03 2011' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">anticipated.&#160; We believe the speed of adoption is beginning to intensify, especially in the healthcare arena, and remain confident in the Company&#146;s long-term market potential.&#148;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Liquidity and Capital Resources</font></u></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Consolidated cash, cash equivalents and accounts receivables totaled over $1.6 million on March&nbsp;31, 2011 compared to $1.4 million as of December&nbsp;31, 2010.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Highlights for the first quarter included the following:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Initial delivery of a multi-million dollar contract to utilize BIO-key&#146;s software for a large scale identity project which includes fingerprinting and registering the entire population of mobility users in an unnamed foreign country.&#160; The majority of the project is expected to be delivered in the first half of 2011.</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Purchase orders from McKesson for their continued deployment of our identification technology in their AccuDose&#174; product line.</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Purchase orders for continued expansion of biometric ID deployments with commercial partners ChoicePoint /Nexis Lexis, Educational Biometric Technology,&nbsp;Identimetrics and Genesis Healthcare.</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Executed an OEM agreement with Oracle to include BIO-key software as the exclusive biometric solution in the release of Oracle&#146;s new UAM product.</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Nationwide Children&#146;s Hospital, one of the largest pediatric hospitals and research institutes in the U.S. launched the initial implementation of BIO-key software through EPIC as the first phase of a rollout to include 6,500 users.</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">A contract with Robinson Memorial Hospital to include our biometric software along with Allscripts Sunrise Client Manager.</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Launched a new program with OEM partner Softex to integrate BIO-key&#146;s algorithm within Softex software to provide fingerprint sign on and authentication for 10,000 retail employees of a major wireless telecommunications company.</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Awarded a contract from a leading supplier of consumer loyalty management services in Panama to include BIO-key finger biometrics software for identification of users.</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\106459\11-12050-1\task4678873\12050-1-mm.htm',USER='106459',CD='May 11 13:03 2011' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Signed two new customers through Davisco, a real-time data collection and reporting company for workplace management functionality, servicing Fortune 500 companies and large government agencies.</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Conference Call Details</font></u></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">BIO-key has scheduled a call for Thursday May&nbsp;12th at 10:00&nbsp;a.m. Eastern Time to discuss 2011 first quarter results.&nbsp; To access the conference call live, dial 800-860-2442 and ask for the BIO-key call at least 10 minutes prior to the start time.&nbsp; The conference call will also be broadcast live over the Internet by logging onto <b>www.bio-key.com</b>. A telephonic replay of the conference call will be available through June&nbsp;12, 2011 and may be accessed by dialing 412-317-0088 and using the pass code 450863#. A streaming audio replay of the webcast will be available shortly after the call on the Company&#146;s website (www.bio-key.com) for a period of thirty days.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">About BIO-key</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">BIO-key International,&nbsp;Inc., headquartered in Wall, New Jersey, develops and delivers advanced identification solutions to commercial and government enterprises, integrators, and custom application developers.&nbsp;BIO-key&#146;s award winning, high performance, scalable, cost-effective and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise applications. Our solutions are used in local embedded OEM products as well as some of the world&#146;s largest identification deployments to improve security, guarantee identity, and help reduce identity theft.&nbsp;&nbsp;BIO-key&#146;s technology is offered directly or by market leading partners around the world. (<b>http://www.bio-key.com</b>)</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">BIO-key Safe Harbor Statement</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Certain statements contained in this press release may be construed as &#147;forward-looking statements&#148; as defined in the Private Securities Litigation Reform Act of 1995 (the &#147;Act&#148;).&nbsp; The words &#147;estimate,&#148; &#147;project,&#148; &#147;intends,&#148; &#147;expects,&#148; &#147;anticipates,&#148; &#147;believes&#148; and similar expressions are intended to identify forward-looking statements.&nbsp; Such forward-looking statements are made based on management&#146;s beliefs, as well as assumptions made by, and information currently available to, management pursuant to the &#147;safe-harbor&#148; provisions of the Act.&nbsp; These statements are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of these statements.&nbsp; These risks and uncertainties include, without limitation, our history of losses and limited revenue, our ability to develop new products and evolve existing ones, the impact on our business of the recent financial crisis in the global capital markets and negative global economic trends, and our ability to attract and retain key personnel.&nbsp; For a more complete description of these and other risk factors that may affect the future performance of BIO-key International,&nbsp;Inc., see &#147;Risk Factors&#148; in the Company&#146;s Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2009 and its other filings with the Securities and Exchange Commission.&nbsp; Readers are</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\106459\11-12050-1\task4678873\12050-1-mm.htm',USER='106459',CD='May 11 13:03 2011' -->

<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made.&nbsp; The Company also undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#169; Copyright 2011 by BIO-key International,&nbsp;Inc.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\106459\11-12050-1\task4678873\12050-1-mm.htm',USER='106459',CD='May 11 13:03 2011' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g120501mmi001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g120501mmi001.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!P@'!@H("`@+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!#`0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P``1"`",`,`#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#V7-&:**`#
M-&:*0D`$G@"@!<T9KD-?^(^DZ2S06A^WW*\;8CA%/NW^&:\]U?QUK^L%E>[-
MK"?^65O\HQ[GJ:PGB(1TW.^AE]:KK:R\SV+4->TG2A_IVH6\!_NLXW?EUKG;
MOXH^'K<D0?:;HC_GG'@?FV*\=)R2S')/4D\UHZ=X?UC5L?8=.GF4_P`>W"_F
M>*YGB9R^%'I1RNA35ZLOT.[F^+L7_+#1I#[R3`?R!J#_`(6[<?\`0&C_`._Y
M_P`*S[/X5Z[.`;F>UM0>Q8N?TX_6M:'X0IC]_K3Y](X`/YFFGB&2UEL-'K]X
MR/XO/G][HHQ_L3_XBM&U^+.CR$"YLKN#W`5Q^AJ$?"/3\<ZK=D_[BU!-\(8\
M?N-:<'TD@!_D:I?6$9/^S9=U]YU5AXU\.ZD0L&IQ*Y_@E_=G]:W%=74,I#*>
MA!R#7DEY\*=:A!-O<VER/[I)0_KQ68L/C#P@^]$O+6-3SC]Y$?J.15^VG'XX
MF;P5"I_!J+T?]?H>WYHS7G6@_%2&4K#K<`A)X^T0C*_BO4?AFN_M;J"]MTN+
M:9)HG&5=&R#6\*D9[,X*V'J47::)LT9HHJS`,T9HHH`,T9HHH`,T44"@`HHK
M+\0:]:>'M,>]NVR>D<8/S2-Z"DVDKLJ,7)J,=R76-:L-#L6N[^81H.%'5G/H
M!W->1>)O'6I>(&:"(M:6/:%&^9Q_M'O].E9.MZY?:_J#7E[)D](XQ]V-?051
MBBDGE2*)&DD<[511DL?05YU6NYNT=CZ3"8"%%<]367X(9P!Z"NE\.^!=6\0!
M9MOV2T/_`"WE'WA_LKW_`)5V'A+X<P62QWVMHL]S]Y;<\I']?[Q_2N]``&!P
M!T%72PU]9F&*S2SY:/W_`.1S6B^`M"T8*_V;[7<#_EK<?-S[#H*Z4`*````.
M@%+17;&*BK)'ASJ3J.\W<****H@**@N[RVL8#/=W$<$2]7D8**Y/4/BCH-HQ
M2V$]ZP[QKM7\S42G&.[-:=&I5^"-SLZ3J,=J\X_X6Q-.W^B:!)*/^NI8_HM6
M(_B=<Q\WGAJ\C7NR$_U45'MX=SH>`Q"WC^*-W6_`NAZT&=K86UP?^6UOA3GW
M'0UQ,FE^)_AY<M=V3_:]/)S)M!*$?[2_PGW%=GI?Q!\/:HXB%V;68\>7<C9S
M]>GZUTGRR+V96'U!%)PA/WHO7R*C7K4/<JJZ[/\`0Q_#?BBP\2V?G6K;)4'[
MV!C\R'^H]ZVJX/Q#X-N-,O/[?\+?N+J(EI+9/NN.^T?^R]^U=%X8\16_B33!
M<QCRYD.V>$GF-O\`#TJH2=^66YE6I1Y?:4OA_%>IM4445J<H4444`%`HH%`$
M5S<16EM)<3N(XHE+NQZ`"O"O%'B*?Q)J[W3Y6!,K!$?X%]?J>IKMOBGKQBMX
M=$@?YIAYD^/[H/"_B>?PKS"O/Q-2[Y$?0Y7AE&/MI;O84`D@`$D\`#O7K_@3
MP8FBVZZC?Q@ZA*N0#_RP4]A[^OY5S/PS\-KJ&H-J]U'N@M&Q$".&D]?P_F:]
M&O?$>AZ:=M[K%E;L.JR3J#^6:O#4OMLRS/%N_L8/U_R-+%+619^+?#FH2B&T
MURPFD/`1;A<G\,UKYQUKM/#"BJ1UG2@<'4[//_7=?\:GM[RUNPQM;F&<+][R
MI`V/RH`FKE?&/C6#PW']F@59]0D7*QD_+&/[S?X5U)KR'6O#=M_PE,]QK'B7
M38;268R/(]RHEVY^[M]<<>E957-+W#KPD:,IWK.R7XE*PTGQ#X^OS<3SLT2M
MAIY?]7'[*OK["O0M'^'F@Z6JM-;_`&Z<=9+CD9]EZ"M70[_09K..UT2]LYH8
MEPJ6\JM@?0&M6IA1C'5ZLNOCJE3W8>['LAD4$4"!(8DC4=%10!^E/HHK<X3.
MU'P_I&K1E+[3H)L_Q%`&'XCFL)='U7PF?.T:674-.',FGS-ET'K&W]#74W-U
M;V<#3W4\<$2_>DD<*H_$TL$\-U`D]O*DL4@W)(C!E8>H(J'!/7J:QK2BN5ZK
ML0:?J%MJEE'>6DF^*0<'&"#W!'8CTKE=?L7\+ZROBG3D/V=R$U*!!PRD_?`]
M1_GO6TUL-(UP7,`VVNH/LN$'19?X7'U^Z??%:\T,=Q`\,R!XY%*LIZ$'J*37
M,K/=%1FJ<KKX7^0L,J3PI-$X>.10RL.A!Z&GUSOA+S+!;S0)F+-ILN(6/5H6
MY0_AR/PKHJJ+NKF=2/+)H****H@*!10*`/GG5]1EU75[J^E))FE9@#_"N>!^
M55%1I'5$4LS$!0.Y/2O5=;^%UG?W;W6GWC6;2,6>-DWIDG/'0CZ58\,_#FTT
M6\6^O+G[9<1G,8V;40^N.YKS?J]1RU/IEF6'C2]W?L<S\1M#UG1/AY9+I>H?
M9K.R4?;HD8H\SL1SD=1DGBO./AYX1B\:^(WL+FZ>"&.%II&0`LV"!@9^M>W?
M%L?\6VU/_MG_`.C%KRKX,ZE9:/XDU"_U&Y2VMHK!M\CG@9=`*]%*RLCYN4G)
MN3W9H^/_`(16WAK09-9TF]GFCMR/.BGP2%)QD$`="1Q6A\'O%=WK(O/"6K32
M7$#VS&!V8[U7HR;NN,'(],4_XE_%+1-5\-SZ)HDKW4ET0LDVPJB*""<9Y).*
M;\$O!]];7DOB2^A>"%H3%:JXP9-Q!+8],#`]<TR3@/B%X;L_"GBV?2K&25X$
M1'4RD%AN&<9%>P_"GPMIF@^&(?$*S2^??VH>=I'PB*"3P/;U->:_&G_DHUS_
M`-<(O_0:[/6=4DTO]GVP$3;7NX([?(]&)+?H"/QH`Y#QS\2=6\7:H=,T>2:#
M3C)Y<44)(>X.<`MCGGLM='HGP&\^Q2;7-5DAN'&3#;H#L]BQZGZ"N:^"^F)J
M'CV.>5`RV4#SC/\`>X4?^A9_"OHR@#YX\:?"[5/!,(UG3+Z2ZM(F&Z5`8Y8#
MV)P>F>XKL_A1\2KC79?[!UN7S+U4+6]P>LP'56_V@.<]^:]+U"RBU+3KFQG4
M-%<1-&X/H1BOD_3[J?P]XE@N8V*S6-T#D?[+8/Y\T`?7-%-C<21K(O1@"/QI
MU`'SS\9=,U73O$:37VK27MO>EY+>)B0(%!^[CIWZBO6?A82?AOH^?^>;_P#H
M;5Y]^T!_R$=%_P"N,O\`-:Z#PSXVTKP9\,/#\NIK<,+E9%001[NCG.<D`=:`
M/1[RV%W;-"3MS@@^A!R#^8J>N%T3XN^'->U>WTNTAOUGN6VH7A&W/OACBM[Q
M/XPT7PE:+/JMSM:3/EPH-TDGT']3Q0`^YB^S^*K*[7@74#V\GN1\Z_R:MFO)
MI?CCX>NKNW\W2]11(9=ZNI0GH1R,^A-=%J'Q<\*Z?8VEXL]Q=QW8.WR(\E",
M9#`D8//2DE8J3ND=O17`:=\9O#&IZE;V$,.H+)<2+&A:$8!)P,X8FM#Q1\3-
M"\):H--U&.\><QB3]S$"H!Z<DBF2=?0*X_1?B;H6O6ES/91W8-L5#))$%+9!
M/!SC@*2?2NATK5X=51S&C1NGWD;!XR1D$=1D$?4&@"_1110!QOQ:_P"2;:I_
MVS_]&+7DWP>T:PU_7=2TW4H!/;2V)W(21R'0@@CH0:].^,>IV5KX$N[&:YC2
MYN]GDQ$_,^'4G`]`*\[^!4\<7C6XC>15:6R94!.-QW*<#\*`.B\;?!K2+30;
MG4=!:>&>TC,K0R/O610,D#/(.*P/A)X[U"QU^VT"]N'GT^[/EQ+(V3"_\.TG
ML>F/>O7?'.O6>@>$[^>[E57D@>*&,GF1V!``'XU\_?#33)]4\?:4D*%E@F$\
MC#^%5YR?T'XT`:GQH_Y*+<_]<(O_`$&ND\5P/+\`="D49$+0LWT.X?S(KFOC
M1_R46Y_ZX1?^@UZMX?T6+Q%\&[+292%%S8!58_PMG*G\"!0!YU\!YTC\8WD+
M'#2V3;?P937OU?*VB7]_X!\;17%U`Z3V,Q2>$\%E/#`?4'(/TKZ8T;7]+U^Q
M2\TR]BN(G&?E8;E]F'4&@#0)"@DG`')-?(6HM]MUVZ>+D3W+E,=\L<?SKZ`^
M)GQ`L/#^AW.GV=U'-JES&8TCC8$P@\%FQTXZ#UKRWX3^$9?$7BF*]FB)T_3W
M$LK$<,XY5/SY/L*`/2M>^+6F^$=4.ASZ;=7$MK%&)'1E`W%0<<_6LS_A?^E?
M]`.\_P"_JUWVI^#?#>LWK7NI:/;7-PP`:1UY('3-5/\`A6_@W_H7K/\`[Y/^
M-`'E'QDU>'7K;PUJMNCI%=6LDBJ_5<D<&LF3Q7-K7A+0O`VG[(59@ES--@`N
M9"5`/91D$G_)W_CM:V]C<Z#:6L*0P0VTBQQH,!0"N`*YO5?`TD7P_P!*\5V"
MNZ2(1>)G.P[R`X]N`#Z4`>\^$O!^F>$=)BM+2)&F`S-<LHWR-W.>P]!7S_JE
MW<^._B2$FE;;=WHMXQG_`%<6[``_#GZUZM\)O'W_``D6G#1-3ESJ5JGR.QYG
MC'?_`'AW_/UKQV]M'\,^.YK:],L*VUV0[Q\,(R?O+[[3D4`>D_$S6O!6F>&)
M/#&FVEM/>IM6/[.@_P!&(/)9_P"][=>>:I?"[P'J&H:/JW]L6K0:=J-L(X%E
M7YC)GB10>1CU[YKK_!OPT\*:+;QZNLZ:N[#S([N;'EJ.Q"]!]3^E;ND^/-`U
MOQ%/H6G7+7%Q`A<R*N8VQ@$!N^,B@#P[X?W[>#?B0EKJ4:J#*UG.7'W"3@,#
MVY`Y]#7;_&Z]^W7&C^&;.-)+RYE$A^4%@"=J#/49))_"L3XX^&_L&NV^OP)M
MBOALE([2J.#^*_R-2?"Z*]\8^.Y?$NKL)?[-@4!B,#?MVK^@)^M`'J5OX/L[
M7PS::-;;8?LR`>8$SYAVX;<.^[)K0T?1QI:N6D5W8!55%VI&@)(51DG&6/4U
MS6I_%'2+*[:WMK>>]"'#21D*I/L3UK9\-^+]-\3>8EKYD4\8W/#*,,!ZC'!%
M9JK!NR9T2PU:$.>478WJ***T.<YGQCX#TGQK!$+\RPSP`B*>(_,H/4$'@BO.
M;GX!W\4V_3_$$)`.5,L+(P_$$U[96;XCD>+PSJDL3LCI9RLK*<%2$."#0!Y/
M#\"=5NIU?5?$<;*.I1&D;'MN(KT3P]X$TGPOH]Q8:698YKJ,I+>D@S$XP"#V
MQG(`KAM0U7Q#%IO@>YTJYFFNAI\ES-"TC'[4$1&96_O$C.,UO>%[V'QKJ/B;
M9J%V+"X^RM"89V1H<QY(4C[IR,'%`'/S_`62YF::;Q1)*['EY+8LQ^I+UU_@
M/P#+X*-QNUN>_CF4*L++MCCP<Y`R>:S/A]I!DOM8O9M4U2=].U*>UA2:\=TV
M`8&Y3P3SUKG_``;%=ZG;V5S=6GBNY=[DAKN+4,6^!(1G:6S@8YX[&@#O_%O@
M#0_&,0:^B:*Z082ZAX<#T/8CV->;S_`7589V.GZ_;E#WDC9&Q^&:T/%.HQ0>
M-]?;4Y?$365I#`R?V7.R)!E>2_(`R<<_6K&K/XI3X=^&T.I.FK7.H(L<PFR6
M5MY0.R\-QMSVH`J:1\`XDG636=9,T8.3%;1[=W_`C_A7JNE:38:)I\=AIMLE
MM;1#Y40=_4GN?<UQ'A3Q1+XC\=(Y>2$IHY6ZLRQQ#<++M;*^OOZ&L*U\<D_$
M!=8;6XVTZYOFTX6'G?<C``6;;GC+@\^E`'L%%>;>)?#RKX[T6TCU?6(X=6DN
M'N$2_=0-J[@%'\(R>E79KNXTCX@O:Q7%Q-;V?AUI%ADE+;V5^&/JQ`Z]:`,K
MQ)\'+GQ'K=QJ,_B><K*Y:..6'?Y2G^$?,.!]*W?!7P^;PK9WME=ZO)J=G=)L
M^S21[8T'.<`D]<USL.GW]S\/7\;/XDU)=7,#7BLMP1`N"?W?E]-N!BCQ#XDU
MV/7_``_K%AYC(FCB^O+)6.V6/(WX7U`;(^E`$4GP)6'4VN]+\1S6:ART($)+
MQCT#!A^==/XF^&6F>*-.M4O+F8:C;0K$-0`!>7`_C'1O7^M5O"WBB`V/BS79
M+Q[BPM[QI82SD@1^6I"KZ<GIZUD_#3Q-._B!]/O]9347U:V%\BK-O^S2Y.Z+
MKQ\N#CVH`R$^!.K+FW/B:-;4GE5B?G_@.<5Z)X-\!Z1X+MG%D&FNI1B6YEQN
M8>@]![5#X%N[J[N?$@N;B680ZQ+'&'8G8H`PH]![5U9.`2!DT`>:?'#6K&U\
M*1Z1*BRW=[(KQ#O&JGE_Z?B:S;&V/@SX106_^KO]9;S).S!6&?T3`_&LBX\$
M^+_%WQ`&H^(M-:UL?.!D=I%*1PJ<A5Y]/YDT[QIKXU[7&>`_Z';#RK<#I@=6
M_'^6*PKSY8>IWX"A[6LF]EJ<_7<?"B!W\27,X!V1VA5C[EEP/T/Y5P_2O:?A
M[H;:/X<229-MQ>'SG!'('\(_+G\:XL/'FFGV/;S*JH4&NKT.JHHHKU#Y4*@O
MK./4+"XLIBPBN(FB?:<'##!Q^=3T4`8=KX2TZSFT:6)I]VBP-!;9<8*LH4[N
M.3@4[0_"NF>'+S4+G34>,ZC*)98RWRJ1G[H[#DUM4F,T`<SX2?1%GU>WTR2X
M$\EX\]W%<##J[<$@?W>*KV/PZL]-1(K+7M=@A1]ZPQWN$R3D\8Z$U'XP\/WD
M5VGB70"4U&W'[V-1_KD^G<X[=Q6CX5\867B6W"@B"]0?O;=CS]5]1_*LE/7E
MEN=,Z*</:4]5U\BMJRZ-X=U:^U2_M;R6/5XTBNI`GF0HJ@J`0.1D&FZ1X;\.
MW6C:=::=J4MW::?=B[M@)PQC89PO3.WD\&NK=%D0HZAE88*D9!KE=2^'6BWD
MIN+,S:9<'G?:MM&?]W_#%5+F6JU(@J4E:5T^^_X%W_A#-*37-0UF`S6]WJ-N
M;>=HF`&#C+`8X;@<U%)X!\.R>&QH/V)5@6,()E51-P<[M^.N:Q)/!/BVW^6R
M\72L@Z"1G!_F:J2^!/&%Y\MWXD#+WS-(?TXJ'4E_*;K#TG_R]7W,WM>F\-Z9
M>Z7J.I:D[7>DHZP(L@9Y-R[3N4=3@>U84?C3P[=>*5UB+3]4FOWMOLBQ*JLK
M)NW?=SUS4EC\)+=7#ZAJDDOJL*;<_B<FNRTCP[I6A1[=/LTB8C!D/+M]6/-)
M>UD^R*DL)3C97D_N1SD'PWT>Y@4-)JMKI\K^<^D&ZQ`&)S@J.V>P.*Z-M`L6
MUR#5]K":"U:U1`1Y?ED@XQCVK3HK<X#E(OASH4&C7FD0FYCLKVZ%S+$L@QD$
M'8./N\#BM"\\(Z/=7EA>1VRVD]A-YL3VJK&3Q@JV!R".U;=%`'*-\/K,7UW=
MVNM:U9F\G:>6.VN]B%SU.,5U*C:H7).!C)ZFAW6-"[L%51DDG``KS;QC\1@Z
MR:=H4G7Y9+L?R3_'\JB=2,%=F]##SKRY8(?\1/&2A)-"TV7+'Y;J53T']P>_
MK^5>:4O4Y/7UK:\,>&+OQ+?^5$#';1D>=.1PH]!ZGVKS)2E5D?44J=+"4M]%
MNS1\!>%FU[5!=W,?^@VK`MD<2/V7^IKV<#`Q573=.M=*L(K*SB$<,0PH]?<^
MI-6A7HTJ:IQL?-XO$O$5.;IT"BBBM3D"BBB@`HHHH`*X?Q9X#-Y<'5]"?[+J
M"'>R*VT2'U![-^AKN**B4%)69K2JSI2YH,\TT;XDW6G3G3_$UK(LD9VM,J8=
M?]Y>_P!17?Z=JUAJT`FL+N*X3_8;)'U'454UWPSI?B&'9?6X,@'R3)PZ?0_T
M-><ZI\/->T.<W6CSO=(O(:%MDJ_AW_"L6ZE/S1VJ.&Q&SY)?@>NT5XS:?$/Q
M/I4GD7;K<%."EU%A_P`Q@UO6OQ=3`%YH[@]S#,"/R(IK$4WOH*>6XB.ROZ,]
M(HKB(_BMH3#]Y;7L9_ZY@_UIY^*GAT#A+T_]L1_C5^VI]S#ZGB/Y&=I17`3_
M`!;TU1_H^F74I[;V5/\`&L:]^*^JS`K9V-O;#LSDR'^@J7B*:ZFD,OQ,OLV/
M5R0`2>`.YKF=<\?Z)HP:-9_MER/^64!S@^[=!7D^I^)-:UC(OM1FD0_\LU.U
M/R'%98'10.3T`K">*?V4>A1RE+6K+[C?\1>,M5\1$QS2>1:YXMXCA3_O'^*L
M#@5T.C>!M>UDJR6AMH#_`,MKCY1CV'4UZ+X?^'FDZ,5GN!]NNEY#RK\JGV7_
M`!S64:52J[LZZF+PV%CR0^Y'#^%O`%]KK)<WH>SL>NXC#RC_`&1V'N:];T_3
MK32[*.SLH5AAC&`J_P`SZGWJR*6NZG2C36AX.)Q=3$/WMNP4"B@5J<@44M%`
M"44M%`"44M%`"44M%`"48I:*`*=_I.GZI'LOK.&X'_31`2/H>U<Q??"[0+DE
MK<W%FQ_YYR;E_)LUV=%1*$9;HVIUZM/X)-'F-Q\(I03]EUA2.PEAQ^H-53\)
M=6SQJ5F?P?\`PKUBBLWAZ;Z'4LRQ*^U^"/)_^%2ZM_T$;+\G_P`*F@^$5X3_
M`*1J\*C_`*9PD_S(KU*BE]6I]@>98E]?P1PMG\)]'A(-W=W5T1V!"#].?UKI
M=-\,Z-I.#9:=!$P_CV[F_,\UJT5K&G".R.:IB:U3XI-B8HI:*LP$HI:*`$HI
%:*`/_]D_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
